Terms: = Colorectal cancer AND FH, HLRCC, 2271, ENSG00000091483, MCUL1, MCL, LRCC, P07954 AND Clinical Outcome
4 results:
1. Predicting clinical outcome of 5-fluorouracil-based chemotherapy for colon cancer patients: is the CpG island methylator phenotype the 5-fluorouracil-responsive subgroup?
Iacopetta B; Kawakami K; Watanabe T
Int J Clin Oncol; 2008 Dec; 13(6):498-503. PubMed ID: 19093176
[TBL] [Abstract] [Full Text] [Related]
2. Changes in mcl-1 expression in rectal cancer in relation to neo-adjuvant radiotherapy.
Ulrich-Pur H; Erovic BM; Soleiman A; Jech B; Pennwieser W; Czembirek C; Zielinski CC; Thurnher D
Wien Klin Wochenschr; 2005 Feb; 117(4):136-40. PubMed ID: 15847193
[TBL] [Abstract] [Full Text] [Related]
3. Rb, mcl-1 and p53 expression correlate with clinical outcome in patients with liver metastases from colorectal cancer.
Backus HH; van Riel JM; van Groeningen CJ; Vos W; Dukers DF; Bloemena E; Wouters D; Pinedo HM; Peters GJ
Ann Oncol; 2001 Jun; 12(6):779-85. PubMed ID: 11484952
[TBL] [Abstract] [Full Text] [Related]
4. outcome after ovarian/adnexal metastectomy in metastatic colorectal carcinoma.
Rayson D; Bouttell E; Whiston F; Stitt L
J Surg Oncol; 2000 Nov; 75(3):186-92. PubMed ID: 11088050
[TBL] [Abstract] [Full Text] [Related]
